ENCOMPASS HEALTH CORP (EHC)
US29261A1007 - Common Stock
| TTM (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 488.50M | 463.00M | 365.90M | 517.20M | 368.80M | |||
| Depreciation Amortization | 280.30M | 273.90M | 243.60M | 256.60M | 243.00M | |||
| Income Taxes - Deferred | 6.40M | 3.90M | 27.90M | 27.80M | 52.40M | |||
| Change In Working Capital | 10.80M | 50.30M | -30.40M | -118.00M | -7.30M | |||
| Interest Paid | N/A | 147.70M | 178.40M | 168.40M | 168.40M | |||
| Taxes Paid | N/A | 109.30M | 50.20M | 129.60M | 32.90M | |||
| Other non cash items | 75.70M | 59.70M | 98.80M | 32.20M | 47.80M | |||
| OPERATING CASH FLOW | 861.70M | 850.80M | 705.80M | 715.80M | 704.70M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -625.90M | -583.10M | -584.10M | -551.20M | -408.20M | |||
| Other Investing Activity | -2.60M | -19.70M | -42.90M | -115.10M | 700.00K | |||
| INVESTING CASH FLOW | -628.50M | -602.80M | -627.00M | -666.30M | -407.50M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -68.70M | -83.30M | -498.20M | -66.30M | 206.70M | |||
| Stock Issued/Repurchased | N/A | N/A | 0.00 | 0.00 | -6.10M | |||
| Dividend Paid | -60.70M | -60.40M | -99.00M | -112.40M | -111.90M | |||
| Other Financing Activity | -50.40M | -53.50M | 451.50M | -61.40M | -234.60M | |||
| FINANCING CASH FLOW | -179.80M | -197.20M | -145.70M | -240.10M | -145.90M | |||
| CHANGE IN CASH | 53.40M | 50.80M | -66.90M | -190.60M | 151.30M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 861.70M | 850.80M | 705.80M | 715.80M | 704.70M | |||
| Capital Expenditure | -625.90M | -583.10M | -584.10M | -551.20M | -408.20M | |||
| FREE CASH FLOW | 235.80M | 267.70M | 121.70M | 164.60M | 296.50M | |||
All data in USD